Key facts
- This page summarizes James Emmett Young's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Jan 2025, 18:03.
James Emmett Young - 27 Jan 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- TLSI
- Reported as of
- 27 Jan 2025
- Net transaction value
- +$129,600
- SEC form
- 4
- Accepted by SEC
- 29 Jan 2025, 18:03:45 UTC
- Prior SEC filing
- 15 Jan 2025
- Next SEC filing
- 06 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Emmett Young
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
James Emmett Young filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 29 Jan 2025.
Change
- Previous filing in this sequence was filed on 15 Jan 2025.
- Current net transaction value: +$129,600.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,500
- Change %
- +135%
- Price
- $0.000000
- Shares after
- 21,726
- Date
- 27 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
TLSI
transaction
Common Stock
Purchase
- Transaction value
- $129,600
- Shares
- +24,000
- Change %
- Price
- $5.40
- Shares after
- 24,000
- Date
- 27 Jan 2025
- Ownership
- By Kathleen A. Young Living Trust
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TLSI
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +75,000
- Change %
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 27 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $5.30
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.
Footnote F4
One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.